Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Autor:
Patricia Palacios-Ozores, José Ramón González-Juanatey, Amparo Martínez-Monzonis, Violeta González-Salvado, Carlos Peña-Gil, Beatriz Rodríguez-Romero, Estíbaliz Díaz-Balboa, Rafael López-López, Milagros Pedreira-Pérez
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-12 (2021)
RUC: Repositorio da Universidade da Coruña
Universidade da Coruña (UDC)
BMC Cardiovascular Disorders
RUC. Repositorio da Universidade da Coruña
instname
RUC: Repositorio da Universidade da Coruña
Universidade da Coruña (UDC)
BMC Cardiovascular Disorders
RUC. Repositorio da Universidade da Coruña
instname
Background Anthracyclines and monoclonal antibodies against human epidermal growth factor receptor-2 (HER2) are frequently used to treat breast cancer but they are associated with risk of developing cardiotoxicity. Implementation of cardioprotective